mRNA-4157 clinical trials

Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors

This study looks at a new treatment called mRNA-4157, sometimes given with other medicines like pembrolizumab, for different solid cancers. Its main goal is to check how safe it is, how well people tolerate it, and how it affects the body's immune system.